Page last updated: 2024-09-04

cyc 202 and aminopurvalanol a

cyc 202 has been researched along with aminopurvalanol a in 2 studies

Compound Research Comparison

Studies (cyc 202)	Trials (cyc 202)	Recent Studies (post-2010) (cyc 202)	Studies (aminopurvalanol a)	Trials (aminopurvalanol a)	Recent Studies (post-2010) (aminopurvalanol a)
979	7	393	9	0	5

Protein Interaction Comparison

Protein	Taxonomy	aminopurvalanol a (IC50)
G2/mitotic-specific cyclin-B2	Homo sapiens (human)	0.034
Cyclin-dependent kinase 1	Homo sapiens (human)	0.034
G2/mitotic-specific cyclin-B1	Homo sapiens (human)	0.034
G2/mitotic-specific cyclin-B3	Homo sapiens (human)	0.034

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ducrot, P; Endicott, J; Grierson, DS; Legraverend, M; Leost, M; Ludwig, O; Meijer, L; Noble, M; Tunnah, P	1
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M	1

Other Studies

2 other study(ies) available for cyc 202 and aminopurvalanol a

Article	Year
Cyclin-dependent kinase inhibition by new C-2 alkynylated purine derivatives and molecular structure of a CDK2-inhibitor complex. Journal of medicinal chemistry, 2000, Apr-06, Volume: 43, Issue:7 Topics: Adenine; CDC2 Protein Kinase; CDC2-CDC28 Kinases; Crystallography, X-Ray; Cyclin B; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; Enzyme Inhibitors; Humans; Models, Molecular; Molecular Structure; Protein Serine-Threonine Kinases; Purines; Roscovitine; Structure-Activity Relationship	2000
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases. Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51 Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases	2007

Article

Year

Cyclin-dependent kinase inhibition by new C-2 alkynylated purine derivatives and molecular structure of a CDK2-inhibitor complex.

Journal of medicinal chemistry, 2000, Apr-06, Volume: 43, Issue:7

Topics: Adenine; CDC2 Protein Kinase; CDC2-CDC28 Kinases; Crystallography, X-Ray; Cyclin B; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; Enzyme Inhibitors; Humans; Models, Molecular; Molecular Structure; Protein Serine-Threonine Kinases; Purines; Roscovitine; Structure-Activity Relationship

2000

A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.

Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007